{"organizations": [], "uuid": "eb807426dabafb1a95cd2ec0daa381d7c44a3ac3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180402.html", "section_title": "Archive News &amp; Video for Monday, 02 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-aileron-therapeutics-reports-q4-lo/brief-aileron-therapeutics-reports-q4-loss-of-0-47-per-share-idUSASC09UJL", "country": "US", "domain_rank": 408, "title": "BRIEF-Aileron Therapeutics Reports Q4 Loss Of $0.47 Per Share", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-03T04:21:00.000+03:00", "replies_count": 0, "uuid": "eb807426dabafb1a95cd2ec0daa381d7c44a3ac3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-aileron-therapeutics-reports-q4-lo/brief-aileron-therapeutics-reports-q4-loss-of-0-47-per-share-idUSASC09UJL", "ord_in_thread": 0, "title": "BRIEF-Aileron Therapeutics Reports Q4 Loss Of $0.47 Per Share", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "aileron therapeutics inc", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 2 (Reuters) - Aileron Therapeutics Inc:\n* AILERON THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 LOSS PER SHARE $0.47 * Q4 EARNINGS PER SHARE VIEW $-0.44 â€” THOMSON REUTERS I/B/E/S\n* GAAP LOSS PER SHARE $0.47 * BELIEVES CASH, CASH EQUIVALENTS, INVESTMENTS AS OF DEC 31 TO ENABLE CO TO FUND OPERATING EXPENSES, CAPEX INTO H2 2019 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-03T04:21:00.000+03:00", "crawled": "2018-04-03T16:11:08.003+03:00", "highlightTitle": ""}